The Therapeutic Effects of Insulin and Berberine on Stress Hyperglycemia

Clinical Trial ID NCT02806999

Rank	Title	Journal	Year	PubWeight™‹?›
1	Intensive insulin therapy in critically ill patients.	N Engl J Med	2001	40.00
2	Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.	JAMA	2008	10.15
3	Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.	Lancet	2000	8.46
4	Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states.	Diabetes	2006	4.14
5	Stress hyperglycaemia.	Lancet	2009	3.13
6	Evaluation of insulin sensitivity in clinical practice and in research settings.	Nutr Rev	2003	1.44
7	Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trial.	Circulation	2014	0.82
8	Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress.	Acta Pharmacol Sin	2016	0.82
9	Intraoperative management of hyperglycemia in the cardiac surgical patient.	Semin Thorac Cardiovasc Surg	2006	0.77
10	Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats.	Br J Pharmacol	2016	0.75